Skip to content

Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes (M-STAR Study)

Targeting Sleep Homeostasis to Improve Alcohol Use Disorder Treatment Outcomes

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04457674
Enrollment
134
Registered
2020-07-07
Start date
2020-11-12
Completion date
2026-03-31
Last updated
2026-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Use Disorder, Insomnia

Keywords

Cognitive Behavioral Therapy, Sleep Hygiene

Brief summary

Insomnia is common in people who are in treatment for alcohol use disorder. It can impact both sleep quality and daytime functioning, as well as make it harder to treat the underlying alcohol use disorder. This study is looking at two types of therapy to help manage insomnia specifically for people also in treatment for alcohol use disorder.

Interventions

CBTi consists of six weekly sessions of individual therapy with a trained therapist, delivered via telemedicine.

SHE participants receive six weekly sessions of individual therapy with a trained therapist, delivered via telemedicine.

Sponsors

University of Michigan
Lead SponsorOTHER
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Meet probable Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria for Alcohol Use Disorder with ≤12 months of abstinence * Planned enrollment into an abstinence-based treatment program * Meet probable DSM-5 criteria for chronic insomnia * Access to a video chat-capable device and reliable Wi-Fi network

Exclusion criteria

* Diagnosis of, or high suspicion for, sleep disorders other than insomnia * Meet probable DSM-5 criteria for bipolar disorder, psychotic disorder, or post-traumatic stress disorder (PTSD) * Terminal or progressive physical illness (e.g., cancer), neurological degenerative disease (e.g., dementia), or presence of an unstable medical condition that is the specific cause of insomnia * Self-reported pregnancy or intention to become pregnant during the study

Design outcomes

Primary

MeasureTime frameDescription
Score from the insomnia severity index (ISI)Immediately post treatmentThe ISI is a 7-item self-report assessment of the nature, severity and impact of insomnia. Scores range from 0-28 with higher scores suggesting more clinically significant insomnia.
Percent days abstinent from alcohol as documented in the timeline follow-back (TLFB)Immediately post treatmentThe Alcohol TLFB is an interviewer-based drinking assessment method to estimate drinking behaviors, including both frequency and quantity of consumption.

Secondary

MeasureTime frameDescription
Score from Multidimensional Fatigue Inventory (MFI), General Fatigue sub-scaleImmediately post treatmentThe MFI is a 20-item assessment that provides an overall fatigue score (20-100) in addition to 5 separate dimensions of fatigue: general fatigue, physical fatigue, reduced motivation, reduced activity, and mental fatigue. Sub-scale scores range from 4-20 with higher scores indicating higher levels of fatigue.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJ Todd Arnedt, Ph.D.

University of Michigan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026